Community

The Forum of Young Global Leaders is a community of innovators from diverse backgrounds and experiences. Search current members and alumni by year awarded, sector or region.

Griffin Myers

Co-founder and Board Member, Oak Street Health, USA

Dr. Griffin Myers is a Co-founder and Chief Medical Officer at Oak Street Health, (NYSE: OSH), a network of primary care centers that delivers value-based care to older adults. He serves on the Board of Directors and is involved in supporting the 5,000+ employees caring for Oak Street Health patients.

Prior to Oak Street Health, Dr. Myers did his residency in emergency medicine at Harvard Medical School at the Brigham and Women’s and Massachusetts General Hospitals. Dr. Myers has a B.S. from Davidson College, an M.B.A. from the University of Chicago Booth School of Business, and an M.D. from the University of Chicago Pritzker School of Medicine. He is a fellow of the American College of Emergency Physicians, a Research Associate at Harvard Medical School, an Adjunct Instructor at Northwestern University, a Presidential Leadership Scholar, and an Aspen Health Innovators Fellow. He splits his time between New York City and Jackson Hole, Wyoming.

Chinny Ogunro

Chief Operating Officer, The Africa Center, USA

Dr. Chinny Ogunro is the Chief Operating Officer of The Africa Center, a New York based non-profit that seeks to serve as a hub for the exchange of ideas around culture, business, and policy related to the continent, and in the spirit of collaboration and engagement with individuals and institutions who share the Center’s values. The mission of the organisation is guided by a leadership team that includes Board Co-Chairs Chelsea Clinton and Hadeel Ibrahim, and Board President Halima Aliko Dangote.

Previously, she was the Chief Executive Officer of WellSpring Health, an Africa-focused integrated care consortium backed by DAI, committed to delivering quality, affordable healthcare at scale. Chinny is a co-founder of Africa Health Holdings (AHH), a healthcare investment and operations company in which she raised over $13M in investor funding. AHH was born out of her doctoral research and her first company, CarePoint Hospitals and Clinics.

Chinny also currently serves as Director of Health Research at the Center for the Study of the Economies of Africa, where her research has explored innovative business models for health care delivery in growth economies, particularly Sub-Saharan Africa and Southeast Asia. She was also a Senior Director at BroadReach Group, responsible for technology implementation and operational excellence. She is the founder of Company Is You, a professional development edtech firm that prepares individuals and companies for the future of work.

Her work in healthcare operations has delivered high-quality, low-cost healthcare to over 40,000 patients across West Africa and India. Her research has received over $700,000 in direct support from organizations such as the Bill & Melinda Gates Foundation and the World Bank.

Chinny is an advisory board member at Growth Capital—the investment arm of CCHub, a Steering Committee member of the Africa Leadership Academy’s Health Network, serves on the leadership committee of MIT Solve, and is frequently a guest lecturer at top international business schools. She has previously worked at Morgan Stanley, Veralon Partners, and provided long-term consultancy for the Nigerian Federal Ministry of Health, the U.N. Special Envoy for Malaria, as well as multiple other development and partner organizations.

Chinny holds a Ph.D in Health Management (Technology and Operations Management, Strategy) from the Harvard Business School, a M.A. in Health Administration from Cornell University, and Bachelors degrees from Stanford University.

Eva Otieno

Co-Founder, Filamujuani Foundation, USA

Eva Otieno is a connector between governments and institutional investors to channel much needed capital into Africa. As a strategist, she discusses Africa-focused market opportunities in order to attract financial flows into the region's local currency and hard currency fixed-income securities. Otieno has led roadshows in the region with investors that have combined assets under management of an estimated $50 billion, which is substantial capital that is seeking for robust returns in frontier Africa. Otieno also participates in thought leadership and media events through providing market insights where solutions are deliberated on how to attract capital into the region. In her role, she also engages with policy-makers to discuss solutions in fixed-income markets. Eva also engages with corporate clients where she provides market insights. This information assists the clients in making decisions as to which country to invest in bringing much needed Foreign Direct Investment (FDI).

Lee Redden

Entrepreneur and Co-Founder, Hands On Robotics, USA

Lee is a visionary technologist and remarkable people leader. His technical genius, loving, positive nature, and intense curiosity propelled him to successfully build a revolutionary company in the agriculture space, Blue River Technologies. They are building robots with cameras that detect every plant and spray just the weeds. Lee has been passionate about bringing this technology to market and its significant impact on improving agriculture on a global scale. Because of the technical decisions Lee helped make early on, this technology can scale across the earth, and it's impressive that he's attained market dominance in this innovative multidisciplinary area seeing this cause through for so long (10+ years). Lee is an active leader in the Forbes 30 under 30 community leading international travel, hosting dinner events, and accelerating this group's mission. Lees has been an active mentor to startups, working with several in the technology and cancer detection space. His philanthropic efforts include advising and donating to a non-profit called Marci, an organization that combats child sex trafficking, and co-founding the non-profit Hands-On Robotics that is developing dog robots for education purposes. Lee has been a speaker at multiple technology and educational conferences, led John Deers' internal training in machine learning of 5,000 employees and over 100 engineers, and has made curriculum recommendations changes to over ten universities in the US.

Carol Reiley

Founder and Chief Executive Officer, Reiley Consulting, USA

An entrepreneur and an active advocate for diversity/bias in AI, Carol E. Reiley has touched many applications of AI/robotics: healthcare (Intuitive Surgical), space (Lockheed Martin), self-driving cars, etc. She co-founded and was president of the leading start-up drive.ai where she led partnerships with Lyft and Grab and raised over $77 million. She founded Tinkerbelle Labs, specializing in low-cost healthcare. She was an instructor at Johns Hopkins and led a robot outreach event for low-income students. She's written a top selling children's book, is a brand ambassador for Guerlain and was selected by Forbes and MIT Tech Review as one of the top women in AI.

James Rogers

Founder and Chief Executive Officer, Apeel, USA

James Rogers, is preoccupied with tipping civilization into an era that will allow us to regard the ‘plastic age’ the same way we regard the ‘stone age’. After receiving his PhD from UCSB in Materials, James founded Apeel with two graduate school friends. Apeel uses materials found in nature to create an invisible ‘peel’ on the outside of fruits and vegetables that allows them to live 2-3x longer. James’ time building Apeel led him to think of technology as a catalyst for system change. He is obsessed with expanding our concept of community beyond the people that we can keep track of on our own mental ledger.

Michele Romanow

Co-Founder and Executive Chairman, Clearco, Canada

Michele Romanow is a serial entrepreneur who started six companies before her 35th birthday. A “Dragon” on CBC’s hit show Dragons’ Den (Canada’s Shark Tank), Michele is the Co-founder and Executive Chairman of Clearco (formerly Clearbanc). Clearco has invested more than $5B+ into 10000+ companies making them the biggest ecommerce investor in the world. She previously co-founded SnapSaves, acquired by American tech giant Groupon, and Buytopia.ca, which acquired ten competitors, including Shop.ca and WagJag.

A prolific investor, Michele was recently named Fortune’s 40 under 40, a Young Global Leader by the World Economic Forum, one of Canada’s Most Powerful Women, Canada’s Angel Investor of the Year and winner of RBC’s Women of Influence, Innovation Award.

Michele co-founded the Canadian Entrepreneurship Initiative with Richard Branson to encourage more women entrepreneurs. Michele has worked driving new digital solutions to many of the world’s leading brands, including P&G, Netflix, Starbucks, and Cirque du Soleil. In addition, she’s advised Fortune 100s and governments on innovation, AI, blockchain and the new economy.

During her Civil Engineering undergrad at Queen’s University, Michele founded The Tea Room, the first zero-consumer-waste coffee shop. At Queen’s, she was given the Queen’s Tricolour — the highest honor awarded by the university — and, after completing her Queen’s MBA, she founded Evandale Caviar, a vertically integrated commercial fishery.

Michele is a director for Vail Resorts (NYSE: MTN), BBTV and Queen’s School of Business. Previously she was a director for Freshii, Whistler Blackcomb, SHAD International and League of Innovators.

Veronica Ruiz del Vizo

Chief Executive Officer and Founder, Working on Solutions, USA

Co-Founder and Chief Executive Officer of WOS. Veronica Ruiz del Vizo has led the communication strategist of global brands, advised Venezuelan foundations, celebrities and democratic organizations on digital strategy. She is also the Co-Founder and Director of Bootcamp Vero, Team Remoto, Amarillo and Dar Learning reaching more than 20,000 online students around the world only during the first year of the pandemic.

Kaitlyn Sadtler

Investigator; Chief of Section, Immunoengineering, National Institutes of Health, USA

Kaitlyn Sadtler is a scientist and Chief of the Section on Immuno-Engineering at the National Institutes of Health. She began her lab at the National Institute of Biomedical Imaging and Bioengineering after a postdoctoral fellowship at the Massachusetts Institute of Technology in the Department of Chemical Engineering working on the molecular mechanisms of immune activation in the foreign body response with Dr Robert Langer (founder of Moderna). There, she was awarded a competitive NIH Postdoctoral Fellowship for her work on immunology and tissue engineering. She completed her PhD at the Johns Hopkins University School of Medicine where she showed a critical role for Th2-T cells in biomaterial-mediated muscle regeneration. Her research has been published in journals such as Science, Nature Methods, Nature Communications and Science Translational Medicine. She was recognized as a 2018 TED Fellow and delivered a TED talk that was listed as one of the top-viewed talks of 2018. Sadtler was selected for the 2019 Forbes 30 Under 30 List in Science and received the 2021 Outstanding Recent Graduate Award from Johns Hopkins University. Since starting her laboratory at the NIH, she has lent her lab's expertise to the fight against COVID-19, launching the NIH Serologic Survey, detecting 16.8 million undiagnosed SARS-CoV-2 infections in the US via remote blood sampling and antibody testing. This work continues as the team works to map the spread of the pandemic in the US from 2020 through 2021.

Aron Schwarzkopf

Founder and Chief Executive Officer, Kushki, USA

Mr. Aron Schwarzkopf is a distinguished Ecuadorian-American serial entrepreneur with a remarkable track record in the fintech industry. He currently holds the position of Co-Founder and CEO at Kushki, a fintech company pioneering digital payment solutions across Latin America. Before his role at Kushki, he served as the Founder and CEO of Leaf, a financial technology company that was eventually acquired by Heartland Payment Systems (NYSE: GPN).

In recognition of his contributions to the global business landscape, Mr. Schwarzkopf was elected as a Young Global Leader by the World Economic Forum. He actively engages in mentorship roles at Techstars, New York, and MIT Angels, demonstrating his commitment to fostering the growth of emerging talent in the entrepreneurial ecosystem. Raised in Quito, Ecuador, he currently resides in Miami, Florida, with his wife and daughters. Mr. Schwarzkopf's diverse educational journey includes stints at Singularity University, The Chinese University of Hong Kong, and Babson College.

Kabir Sehgal

Founder and Chief Executive Officer, Tiger Turn Productions, USA

Kabir Sehgal is a 15x Grammy Award Winning Artist/Producer/DJ.

He is the CEO of Tiger Turn, a multimedia company & record label that makes music and film.

He is also a New York Times & Wall Street Journal bestselling author of 18 books such as “Coined” and “Carry On.” He is a CNBC, HBR, and Fortune contributor.

Sehgal is a US Navy veteran and reserve officer.

Previously, he was a vice president at J.P. Morgan and First Data.

He is a graduate of Dartmouth College and the London School of Economics.

Emily Serazin

Managing Director and Partner, Boston Consulting Group (BCG), USA

Emily Serazin is a Managing Director and Partner at the Boston Consulting Group (BCG). Emily is a core member of BCG’s Health Care and Social Impact practices. Within health care, Emily’s focus is on vaccines and global health across the value chain. She also has expertise in digital health and in the formation and optimization of public-private partnerships. Examples of Emily's experience in the commercial health care sector include developing growth and product launch strategies for players in the global vaccines market, leading due diligences, and supporting post-merger integrations. In the realm of global public health, Emily has worked across leading global health institutions such as Gavi, UNICEF, WHO, and the Bill & Melinda Gates foundation to define investment strategies, coordinate multi-stakeholder efforts, prioritize portfolios, and identify key levers to drive uptake in low- and middle-income countries. Since the start of the Covid-19 pandemic, Emily has worked extensively with public, private and social sector actors to accelerate the development and deployment of Covid-19 vaccines and therapeutics.